Skip to NavigationSkip to content

Pharmafile - Business Services News

The drug candidate is targeted to treat non-small cell lung cancer in patients who have already had therapy for the disease  
AML is an aggressive blood cancer and treatment options have stagnated in over three decades
Trial showed overall survival rose by 19% and the drug also improved quality of life
Hopes to close deal by mid-2016 and says merger is targeted at creating a global biotechnology firm focused on rare diseases 
J&J to also invest $50 million in Tesaro’s stock 
Pfizer to pay $150 million in reimbursement to Allergan
The agency alleges Endo paid hundreds of millions of dollars to generics makers to hold off patent filing for drugs 
Compensation up over four times
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches